[1]Tetrahedron,1989,vol.45,p.4619-4626
[1]Cowling,AntonyP.;Mann,John;Usmani,AttiqueA.[JournaloftheChemicalSociety.PerkintransactionsI,1981,p.2116-2119]
[2]Ansell,MartinF.;Mason,JonathanS.;Caton,MichaelP.L.[JournaloftheChemicalSociety.PerkintransactionsI,1984,#5,p.1061-1068]
[3]Noyori;Sato;Kobayashi[BulletinoftheChemicalSocietyofJapan,1983,vol.56,#9,p.2661-2679]
[4]Eiden;Kainz[ArchivderPharmazie,1992,vol.325,#1,p.17-22]
[5]Foehlisch,Baldur;Sendelbach,Stefan;Bauer,Harald[LiebigsAnnalenderChemie,1987,p.1-5]
[6]Bunn;Cox;Simpkins[Tetrahedron,1993,vol.49,#1,p.207-218]
[1]CurrentPatentAssignee:ASTRAZENECAPLC-US5478842,1995,A
Title: Encapsulation of recombinant E. coli expressing cyclopentanone monooxygenase in polyelectrolyte complex capsules for Baeyer-Villiger biooxidation of 8-oxabicyclo[3.2.1]oct-6-en-3-one.
Journal: Biotechnology letters 20100501
Title: Asymmetric synthesis of the northern half C1-C16 of the bryostatins.
Journal: Organic letters 20010322